These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 26056621

  • 21. Urinary miRNA profile for the diagnosis of IgA nephropathy.
    Szeto CC, Wang G, Ng JK, Kwan BC, Mac-Moune Lai F, Chow KM, Luk CC, Lai KB, Li PK.
    BMC Nephrol; 2019 Mar 04; 20(1):77. PubMed ID: 30832601
    [Abstract] [Full Text] [Related]

  • 22. Elevated hsa-miR-590-3p expression down-regulates HMGB2 expression and contributes to the severity of IgA nephropathy.
    Zhai Y, Qi Y, Long X, Dou Y, Liu D, Cheng G, Xiao J, Liu Z, Zhao Z.
    J Cell Mol Med; 2019 Nov 04; 23(11):7299-7309. PubMed ID: 31557418
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-155-induced T lymphocyte subgroup drifting in IgA nephropathy.
    Yang L, Zhang X, Peng W, Wei M, Qin W.
    Int Urol Nephrol; 2017 Feb 04; 49(2):353-361. PubMed ID: 27796698
    [Abstract] [Full Text] [Related]

  • 24. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL, Ren LF, Wang HP, Bai ZT, Zhang L, Meng WB, Zhu KX, Ding FH, Miao L, Yan J, Wang YP, Liu YQ, Zhou WC, Li X.
    World J Gastroenterol; 2019 Apr 07; 25(13):1580-1591. PubMed ID: 30983818
    [Abstract] [Full Text] [Related]

  • 25. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
    Zhang J, Song Y, Zhang C, Zhi X, Fu H, Ma Y, Chen Y, Pan F, Wang K, Ni J, Jin W, He X, Su H, Cui D.
    Theranostics; 2015 Apr 07; 5(7):733-45. PubMed ID: 25897338
    [Abstract] [Full Text] [Related]

  • 26. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.
    Ramezani A, Devaney JM, Cohen S, Wing MR, Scott R, Knoblach S, Singhal R, Howard L, Kopp JB, Raj DS.
    Eur J Clin Invest; 2015 Apr 07; 45(4):394-404. PubMed ID: 25682967
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy.
    Wang J, Wang G, Liang Y, Zhou X.
    J Diabetes Res; 2019 Apr 07; 2019():5204394. PubMed ID: 31218232
    [Abstract] [Full Text] [Related]

  • 29. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy.
    Guan J, Wang M, Zhao M, Ni W, Zhang M.
    BMC Nephrol; 2023 Mar 20; 24(1):60. PubMed ID: 36941570
    [Abstract] [Full Text] [Related]

  • 30. The Value of Serum IgA in the Diagnosis, Clinical and Pathological Evaluation of Patients with IgA Nephropathy Found During Physical Examination in China.
    Ren L, Zhang C, Pan Y, Sun J.
    Clin Lab; 2019 Dec 01; 65(12):. PubMed ID: 31850707
    [Abstract] [Full Text] [Related]

  • 31. MicroRNAs as a therapeutic target in IgA nephropathy in Indian population.
    Tripathy A, Yedla P, Vishnubhotla RV, Sekaran A, Keithi Reddy SR.
    Biomed Rep; 2023 May 01; 18(5):35. PubMed ID: 37089577
    [Abstract] [Full Text] [Related]

  • 32. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H, Hama Y, Iwata IT, Shirai S, Matsushima M, Yabe I, Utsumi J, Sasaki H.
    Mol Brain; 2019 May 14; 12(1):49. PubMed ID: 31088501
    [Abstract] [Full Text] [Related]

  • 33. [TCM Combined Western Medicine Treatment of Advanced NSCLC: a Preliminary Study of mIRNA Expression Profiles].
    Li YB, Lin LZ, Guan JS, Chen CM, Zuo Q, Lin BQ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Sep 14; 36(9):1076-1081. PubMed ID: 30645846
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Role of IgG antibody to galactose-deficient IgA1 in children with IgA nephropathy].
    Zhou N, Zhang H, Liu XR, Sun Q, Meng Q, Chen Z, Shen Y.
    Zhonghua Er Ke Za Zhi; 2017 Sep 02; 55(9):663-667. PubMed ID: 28881511
    [Abstract] [Full Text] [Related]

  • 36. Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion via miR-98-5p in Pediatric IgA Nephropathy.
    Liu C, Li X, Shuai L, Dang X, Peng F, Zhao M, Xiong S, Liu Y, He Q.
    Front Pharmacol; 2021 Sep 02; 12():658236. PubMed ID: 33935780
    [Abstract] [Full Text] [Related]

  • 37. Increased urinary exosomal microRNAs in children with idiopathic nephrotic syndrome.
    Chen T, Wang C, Yu H, Ding M, Zhang C, Lu X, Zhang CY, Zhang C.
    EBioMedicine; 2019 Jan 02; 39():552-561. PubMed ID: 30467011
    [Abstract] [Full Text] [Related]

  • 38. MicroRNA-21-5p participates in IgA nephropathy by driving T helper cell polarization.
    Xu BY, Meng SJ, Shi SF, Liu LJ, Lv JC, Zhu L, Zhang H.
    J Nephrol; 2020 Jun 02; 33(3):551-560. PubMed ID: 31863364
    [Abstract] [Full Text] [Related]

  • 39. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
    Groen K, Maltby VE, Lea RA, Sanders KA, Fink JL, Scott RJ, Tajouri L, Lechner-Scott J.
    BMC Med Genomics; 2018 May 21; 11(1):48. PubMed ID: 29783973
    [Abstract] [Full Text] [Related]

  • 40. Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Zhang Q, Zhao Y, Luo Y, Guo S, Hou H, Han X, Zhou Y.
    Ren Fail; 2024 Dec 21; 46(1):2319326. PubMed ID: 38379319
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.